İçeriğe geç
akaturk Akademik ölçüm

Makale detayı · 2024 · article

A neurotherapeutic approach with Lacticaseibacillus rhamnosus E9 on gut microbiota and intestinal barrier in MPTP-induced mouse model of Parkinson’s disease

Dergi Scientific Reports ISSN kaydı başka bir dergiye işaret ediyor; ad YÖKSİS kaydından.
ISSN1476-9271
YÖKSİS OpenAlex Açık erişim · gold Üst %10
Yıl2024
Atıf34OpenAlex
Atıf32Semantic Scholar · 2 etkili
Yüzdelik%96,8
FWCI5,241,00 = dünya ortalaması
Scopus (SJR)Q2
WoS (JCR)Q1

Veri kaynağı ayrımı

  • YÖKSİSYÖKSİS makale kaydı
  • YÖKSİS dergi adıScientific Reports
  • Katalog eşleşmesi (ISSN)Computational Biology and Chemistry
  • OpenAlexOpenAlex zenginleştirmesi (özet, atıf, konular)
  • Semantic Scholaratıf sayısı (OpenAlex ile birleştirilmez)

Özet

OpenAlex İngilizce

The gut microbiota plays a crucial role in neural development and progression of neural disorders like Parkinson's disease (PD). Probiotics have been suggested to impact neurodegenerative diseases via gut-brain axis. This study aims to investigate the therapeutic potential of Lacticaseibacillus rhamnosus E9, a high exopolysaccharide producer, on 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine(MPTP)-induced mouse model of PD. C57BL/6 mice subjected to MPTP were fed L. rhamnosus E9 for fifteen days and sacrificed after the last administration. Motor functions were determined by open-field, catalepsy, and wire-hanging tests. The ileum and the brain tissues were collected for ELISA, qPCR, and immunohistochemistry analyses. The cecum content was obtained for microbiota analysis. E9 supplementation alleviated MPTP-induced motor dysfunctions accompanied by decreased levels of striatal TH and dopamine. E9 also reduced the level of ROS in the striatum and decreased the DAT expression while increasing the DR1. Furthermore, E9 improved intestinal integrity by enhancing ZO-1 and Occludin levels and reversed the dysbiosis of the gut microbiota induced by MPTP. In conclusion, E9 supplementation improved the MPTP-induced motor deficits and neural damage as well as intestinal barrier by modulating the gut microbiota in PD mice. These findings suggest that E9 supplementation holds therapeutic potential in managing PD through the gut-brain axis.

Konular

Atıflar

OpenAlex cited_by_count. WoS veya Scopus atıf sayısı değildir; o kaynaklar için ayrı kolon yoktur.

34atıfOpenAlex · cited_by_count (önbellek / veritabanı)

Yerel katalogda bu makaleye atıf yapan 4 yayın (OpenAlex referans eşleşmesi; tam dünya listesi değildir).

  1. 2026 Non-pharmacological interventions modulating immune response in Parkinsons disease: where do we stand for future preventive approachesAtıf 0 · OpenAlex
  2. 2026 Non-pharmacological interventions modulating immune response in Parkinsons disease: where do we stand for future preventive approachesAtıf 0 · OpenAlex
  3. 2026 Gerobiotics and neuroprotection: effects on the gut-brain axis in age-related neurodegenerative diseasesAtıf 0 · OpenAlex
  4. 2026 Gerobiotics and Neuroprotection: Effects on the Gut-Brain Axis in Age-Related Neurodegenerative DiseasesAtıf 0 · OpenAlex

Yazarlar

3
  1. BÜŞRA AKTAŞ MANSUROĞLU 1
  2. BELMA ASLIM GAZİ ÜNİVERSİTESİ 2
  3. DENİZ ATEŞ ÖZDEMİR 3